[
  {
    "ts": null,
    "headline": "A Look At Regeneron Pharmaceuticals (REGN) Valuation After Recent Share Price Pullback",
    "summary": "How Regeneron Pharmaceuticals (REGN) Has Been Trading Recently Regeneron Pharmaceuticals (REGN) has been moving within a mixed performance range, with a 1 day return of about a 1% decline, a 7 day gain of 3.4%, a month decline of 5.6%, and a past 3 months gain of 16.6%. Over longer periods, the stock shows a year to date decline of 1.2%, a 1 year total return of 8.6%, a 3 year total return of 1.8%, and a 5 year total return of 58.7%. See our latest analysis for Regeneron Pharmaceuticals. At a...",
    "url": "https://finnhub.io/api/news?id=4095b8235c3c407bdb426c0463603b6df0b6813f8cf97ea39552258d145c0012",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770397673,
      "headline": "A Look At Regeneron Pharmaceuticals (REGN) Valuation After Recent Share Price Pullback",
      "id": 138376970,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "How Regeneron Pharmaceuticals (REGN) Has Been Trading Recently Regeneron Pharmaceuticals (REGN) has been moving within a mixed performance range, with a 1 day return of about a 1% decline, a 7 day gain of 3.4%, a month decline of 5.6%, and a past 3 months gain of 16.6%. Over longer periods, the stock shows a year to date decline of 1.2%, a 1 year total return of 8.6%, a 3 year total return of 1.8%, and a 5 year total return of 58.7%. See our latest analysis for Regeneron Pharmaceuticals. At a...",
      "url": "https://finnhub.io/api/news?id=4095b8235c3c407bdb426c0463603b6df0b6813f8cf97ea39552258d145c0012"
    }
  },
  {
    "ts": null,
    "headline": "Have originator medicines’ list prices started to drop in the US?",
    "summary": "According to the GlobalData service Price Intelligence (POLI) & HTA, more than 800 originator molecules still posted price hikes to their WACs and AWPs.",
    "url": "https://finnhub.io/api/news?id=216a3325226c91f4f11564af085da262ed665e01f0e3597b4af74d83fee5058f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770388012,
      "headline": "Have originator medicines’ list prices started to drop in the US?",
      "id": 138375445,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "According to the GlobalData service Price Intelligence (POLI) & HTA, more than 800 originator molecules still posted price hikes to their WACs and AWPs.",
      "url": "https://finnhub.io/api/news?id=216a3325226c91f4f11564af085da262ed665e01f0e3597b4af74d83fee5058f"
    }
  }
]